A family of killer toxins: Exploring the mechanism of ADP-ribosylating toxins

FEBS Journal

Volumn 273, Issue 20, 2006, Pages 4579-4593

  Holbourn, Kenneth P ^a   Shone, Clifford C ^b   Acharya, K R ^a  

^a University of Bath   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

ADP ribosylating toxin; ADP ribosyltransferase; GTPases; NAD binding; Structure

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATING TOXIN; ARGININE; BACTERIAL TOXIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG;

BINDING SITE; CATALYSIS; MODEL; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN MOTIF; REVIEW;

ADP RIBOSE TRANSFERASES; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; BINDING SITES; CONSERVED SEQUENCE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NAD; SEQUENCE ALIGNMENT; TOXINS, BIOLOGICAL;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 33749387471     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2006.05442.x     Document Type: Review

References (88)

1. Bell CE & Eisenberg D (1996) Crystal structure of diphtheria toxin bound to nicotinamide adenine dinucleotide. Biochemistry 35, 1137-1149.
2. Li M, Dyda F, Benhar I, Pastan I & Davies DR (1996) Crystal structure of the catalytic domain of Pseudomonas exotoxin A complexed with a nicotinamide adenine dinucleotide analog: implications for the activation process and for ADP ribosylation. Proc Natl Acad Sci USA 93, 6902-6906.
3. Stein PE, Boodhoo A, Armstrong GD, Cockle SA, Klein MH & Read RJ (1994) The crystal structure of pertussis toxin. Structure 2, 45-57.
4. Zhang RG, Scott DL, Westbrook ML, Nance S, Spangler BD, Shipley GG & Westbrook EM (1995) The three-dimensional crystal structure of cholera toxin. J Mol Biol 251, 563-573.
5. Sixma TK, Kalk KH, van Zanten BA, Dauter Z, Kingma J, Witholt B & Hol WG (1993) Refined structure of Escherichia coli heat-labile enterotoxin, a close relative of cholera toxin. J Mol Biol 230, 890-918.
6. Tsuge H, Nagahama M, Nishimura H, Hisatsune J, Sakaguchi Y, Itogawa Y, Katunuma N & Sakurai J (2003) Crystal structure and site-directed mutagenesis of enzymatic components from Clostridium perfringens iota-toxin. J Mol Biol 325, 471-483.
7. Han S, Craig JA, Putnam CD, Carozzi NB & Tainer JA (1999) Evolution and mechanism from structures of an ADP-ribosylating toxin and NAD complex. Nat Struct Biol 6, 932-936.
8. Han S, Arvai AS, Clancy SB & Tainer JA (2001) Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis. J Mol Biol 305, 95-107.
9. Evans HR, Sutton JM, Holloway DE, Ayriss J, Shone CC & Acharya KR (2003) The crystal structure of C3stau2 from Staphylococcus aureus and its complex with NAD. J Biol Chem 278, 45924-45930.
10. Locht C & Keith JM (1986) Pertussis toxin gene: nucleotide sequence and genetic organization. Science 232, 1258-1264.
11. Tamura M, Nogimori K, Murai S, Yajima M, Ito K, Katada T, Ui M & Ishii S (1982) Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model. Biochemistry 21, 5516-5522.
12. Gill DM (1976) The arrangement of subunits in cholera toxin. Biochemistry 15, 1242-1248.
13. Cassel D & Pfeuffer T (1978) Mechanism of cholera toxin action: covalent modification of the guanyl nucleotide-binding protein of the adenylate cyclase system. Proc Natl Acad Sci USA 75, 2669-2673.
14. Streatfield SJ, Sandkvist M, Sixma TK, Bagdasarian M, Hol WG & Hirst TR (1992) Intermolecular interactions between the A and B subunits of heat-labile enterotoxin from Escherichia coli promote holotoxin assembly and stability in vivo. Proc Natl Acad Sci USA 89, 12140-12144.
15. Hwang J, Fitzgerald DJ, Adhya S & Pastan I (1987) Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli. Cell 48, 129-236.
16. Allured VS, Collier RJ, Carroll SF & McKay DB (1986) Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution. Proc Natl Acad Sci USA 83, 1320-1324.
17. Morris RE, Gerstein AS, Bonventre PF & Saelinger CB (1985) Receptor-mediated entry of diphtheria toxin into monkey kidney (Vero) cells: electron microscopic evaluation. Infect Immun 50, 721-727.
18. Sandvig K & Olsnes S (1980) Diphtheria toxin entry into cells is facilitated by low pH. J Cell Biol 87, 828-832.
19. Collier RJ (1975) Diphtheria toxin: mode of action and structure. Bacteriol Rev 39, 54-85.
20. Wilson BA & Collier RJ (1992) Diphtheria toxin and Pseudomonas aeruginosa exotoxin A: active-site structure and enzymic mechanism. Curr Top Microbiol Immunol 175, 27-41.
21. Aktories K, Barmann M, Ohishi I, Tsuyama S, Jakobs KH & Habermann E (1986) Botulinum C2 toxin ADP-ribosylates actin. Nature 322, 390-392.
22. Stiles BG & Wilkins TD (1986) Purification and characterization of Clostridium perfringens iota toxin: dependence on two nonlinked proteins for biological activity. Infect Immun 54, 683-638.
23. Simpson LL, Stiles BG, Zepeda H & Wilkins TD (1989) Production by Clostridium spiroforme of an iotalike toxin that possesses mono (ADP-ribosyl) transferase activity: identification of a novel class of ADP- ribosyltransferases. Infect Immun 57, 255-261.
24. Popoff MR & Boquet P (1988) Clostridium spiroforme toxin is a binary toxin which ADP-ribosylates cellular actin. Biochem Biophys Res Commun 152, 1361-1368.
25. Aktories K, Rosener S, Blaschke U & Chhatwal GS (1988) Botulinum ADP-ribosyltransferase C3: purification of the enzyme and characterization of the ADP-ribosylation reaction in platelet membranes. Eur J Biochem 172, 445-450.
26. Aktories K, Weller U & Chhatwal GS (1987) Clostridium botulinum type C produces a novel ADP-ribosyltransferase distinct from botulinum C2 toxin. FEBS Lett 212, 109-113.
27. Just I, Mohr C, Schallehn G, Menard L, Didsbury JR, Vandekerckhove J, van Damme J & Aktories K (1992) Purification and characterization of an ADP-ribosyltransferase produced by Clostridium limosum. J Biol Chem 267, 10274-10280.
28. Just I, Wilm M, Selzer J, Rex G, von Eichel-Streiber C, Mann M & Aktories K (1995) The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J Biol Chem 270, 13932-13936.
29. Yamaguchi T, Hayashi T, Takami H, Ohnishi M, Murata T, Nakayama K, Asakawa K, Ohara M, Komatsuzawa H & Sugai M (2001) Complete nucleotide sequence of a Staphylococcus aureus exfoliative toxin B plasmid and identification of a novel ADP-ribosyltransferase, EDIN-C. Infect Immun 69, 7760-7771.
30. Wilde C, Chhatwal GS & Aktories K (2002) C3stau, a new member of the family of C3-like ADP-ribosyltransferases. Trends Microbiol 10, 5-7.
31. Han S & Tainer JA (2002) The ARTT motif and a unified structural understanding of substrate recognition in ADP-ribosylating bacterial toxins and eukaryotic ADP-ribosyltransferases. Int J Medical Microbiol 291, 523-529.
32. Jorgensen R, Merrill AR, Yates SP, Marquez VE, Schwan AL, Boesen T & Andersen GR (2005) Exotoxin A-eEF2 complex structure indicates ADP ribosylation by ribosome mimicry. Nature 436, 979-984.
33. Wilde C, Just I & Aktories K (2002) Structure-function analysis of the Rho-ADP-ribosylating exoenzyme C3stau2 from Staphylococcus aureus. Biochemistry 41, 1539-1544.
34. Ritter H, Koch-Nolte F, Marquez VE & Schulz GE (2003) Substrate binding and catalysis of ecto-ADP-ribosyltransferase 2.2 from rat. Biochemistry 42, 10155-10162.
35. Gill DM, Clements JD, Robertson DC & Finkelstein RA (1981) Subunit number and arrangement in Escherichia coli heat-labile enterotoxin. Infect Immun 33, 677-682.
36. Finkelstein RA, Burks MF, Zupan A, Dallas WS, Jacob CO & Ludwig DS (1987) Epitopes of the cholera family of enterotoxins. Rev Infect Dis 9, 544-561.
37. Sixma TK, Pronk SE, Kalk KH, Wartna ES, van Zanten BA, Witholt B & Hol WG (1991) Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. Nature 351, 371-377.
38. Sandkvist M, Bagdasarian M & Howard SP (2000) Characterization of the multimeric Eps complex required for cholera toxin secretion. Int J Medical Microbiol 290, 345-350.
39. Kassis S, Hagmann J, Fishman PH, Chang PP & Moss J (1982) Mechanism of action of cholera toxin on intact cells. Generation of A1 peptide and activation of adenylate cyclase. J Biol Chem 257, 12148-12152.
40. Galloway TS, Tait RM & van Heyningen S (1987) Photolabelling of cholera toxin by NAD+. Biochem J 242, 927-930.
41. Gill DM & Richardson SH (1980) Adenosine diphosphate-ribosylation of adenylate cyclase catalyzed by heat-labile enterotoxin of Escherichia coli: comparison with cholera toxin. J Infect Dis 141, 64-70.
42. Field M, Rao MC & Chang EB (1989) Intestinal electrolyte transport and diarrheal disease. N Engl J Med 321, 879-883.
43. Peterson JW & Ochoa LG (1989) Role of prostaglandins and cAMP in the secretory effects of cholera toxin. Science 245, 857-859.
44. Katada T & Ui M (1982) ADP ribosylation of the specific membrane protein of C6 cells by islet-activating protein associated with modification of adenylate cyclase activity. J Biol Chem 257, 7210-7216.
45. Katada T & Ui M (1982) Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein. Proc Natl Acad Sci USA 79, 3129-3133.
46. West RE Jr, Moss J, Vaughan M, Liu T & Liu TY (1985) Pertussis toxin-catalyzed ADP-ribosylation of transducin. Cysteine 347 is the ADP-ribose acceptor site. J Biol Chem 260, 14428-14430.
47. Van Ness BG, Howard JB & Bodley JW (1980) ADP-ribosylation of elongation factor 2 by diphtheria toxin. Isolation and properties of the novel ribosyl-amino acid and its hydrolysis products. J Biol Chem 255, 10717-10720.
48. Iglewski BH, Liu PV & Kabat D (1977) Mechanism of action of Pseudomonas aeruginosa exotoxin Aiadenosine diphosphate-ribosylation of mammalian elongation factor 2 in vitro and in vivo. Infect Immun 15, 138-144.
49. Aktories K (1990) Clostridial ADP-ribosyltransferases - modification of low molecular weight GTP-binding proteins and of actin by clostridial toxins. Medical Microbiol Immunol (Berl) 179, 123-136.
50. Aktories K & Wegner A (1989) ADP-ribosylation of actin by clostridial toxins. J Cell Biol 109, 1385-1387.
51. Popoff MR, Rubin EJ, Gill DM & Boquet P (1988) Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect Immun 56, 2299-2306.
52. Barth H, Aktories K, Popoff MR & Stiles BG (2004) Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins. Microbiol Mol Biol Rev 68, 373-402.
53. Just I, Selzer J, Hofmann F, Green GA & Aktories K (1996) Inactivation of Ras by Clostridium sordellii lethal toxin-catalyzed glucosylation. J Biol Chem 271, 10149-10153.
54. Chardin P, Boquet P, Madaule P, Popoff MR, Rubin EJ & Gill DM (1989) The mammalian G protein rhoC is ADP-ribosylated by Clostridium botulinum exoenzyme C3 and affects actin microfilaments in Vero cells. EMBO J 8, 1087-1092.
55. Sekine A, Fujiwara M & Narumiya S (1989) Asparagine residue in the rho gene product is the modification site for botulinum ADP-ribosyltransferase. J Biol Chem 264, 8602-8605.
56. Etienne-Manneville S & Hall A (2002) Rho GTPases in cell biology. Nature 420, 629-635.
57. Wilde C & Aktories K (2001) The Rho-ADP-ribosylating C3 exoenzyme from Clostridium botulinum and related C3-like transferases. Toxicon 39, 1647-1660.
58. Aepfelbacher M, Essler M, Huber E, Sugai M & Weber PC (1997) Bacterial toxins block endothelial wound repair. Evidence that Rho GTPases control cytoskeletal rearrangements in migrating endothelial cells. Arterioscler Thromb Vasc Biol 17, 1623-1629.
59. Czech A, Yamaguchi T, Bader L, Linder S, Kaminski K, Sugai M & Aepfelbacher M (2001) Prevalence of Rhoinactivating epidermal cell differentiation inhibitor toxins in clinical Staphylococcus aureus isolates. J Infect Dis 184, 785-788.
60. Schreiber V, Dantzer F, Ame JC & de Murcia G (2006) Poly (ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol 7, 517-528.
61. Ruf A, Mennissier de Murcia J, de Murcia G & Schulz GE (1996) Structure of the catalytic fragment of poly (AD-ribose) polymerase from chicken. Proc Natl Acad Sci USA 93, 7481-7485.
62. Oliver AW, Ame JC, Roe SM, Good V, de Murcia G & Pearl LH (2004) Crystal structure of the catalytic fragment of murine poly (ADP-ribose) polymerase-2. Nucleic Acids Res 32, 456-464.
63. Mueller-Dieckmann C, Ritter H, Haag F, Koch-Nolte F & Schulz GE (2002) Structure of the ecto-ADP-ribosyl transferase ART2.2 from rat. J Mol Biol 322, 687-696.
64. Koch-Nolte F & Haag F (1997) Mono (ADP-ribosyl) transferases and related enzymes in animal tissues. Emerging gene families. Adv Exp Medical Biol 419, 1-13.
65. Glowacki G, Braren R, Firner K, Nissen M, Kuhl M, Reche P, Bazan F, Cetkovic-Cvrlje M, Leiter E, Haag F et al. (2002) The family of toxin-related ecto-ADP-ribosyltransferases in humans and the mouse. Protein Sci 11, 1657-1670.
66. Okazaki IJ & Moss J (1998) Glycosylphosphatidylinositol-anchored and secretory isoforms of mono-ADP-ribosyltransferases. J Biol Chem 273, 23617-23620.
67. Domenighini M & Rappuoli R (1996) Three conserved consensus sequences identify the NAD-binding site of ADP-ribosylating enzymes, expressed by eukaryotes, bacteria and T-even bacteriophages. Mol Microbiol 21, 667-674.
68. Marsischky GT, Wilson BA & Collier RJ (1995) Role of glutamic acid 988 of human poly-ADP-ribose polymerase in polymer formation. Evidence for active site similarities to the ADP-ribosylating toxins. J Biol Chem 270, 3247-3254.
69. Menetrey J, Flatau G, Stura EA, Charbonnier JB, Gas F, Teulon JM, Le Du MH, Boquet P & Menez A (2002) NAD binding induces conformational changes in Rho ADP-ribosylating Clostridium botulinum C3 exoenzyme. J Biol Chem 277, 30950-30957.
70. Nagahama M, Sakaguchi Y, Kobayashi K, Ochi S & Sakurai J (2000) Characterization of the enzymatic component of Clostridium perfringens iota-toxin. J Bacteriol 182, 2096-2103.
71. Vogelsgesang M & Aktories K (2006) Exchange of Glutamine-217 to glutamate of Clostridium limosum exoenzyme C3 turns the asparagine-specific ADP-ribosyltransferase into an arginine-modifying enzyme. Biochemistry 45, 1017-1025.
72. Barth H, Preiss JC, Hofmann F & Aktories K (1998) Characterization of the catalytic site of the ADP-ribosyltransferase Clostridium botulinum C2 toxin by site-directed mutagenesis. J Biol Chem 273, 29506-29511.
73. Carroll SF & Collier RJ (1988) Amino acid sequence homology between the enzymic domains of diphtheria toxin and Pseudomonas aeruginosa exotoxin A. Mol Microbiol 2, 293-296.
74. Carroll SF & Collier RJ (1984) NAD binding site of diphtheria toxin: identification of a residue within the nicotinamide subsite by photochemical modification with NAD. Proc Natl Acad Sci USA 81, 3307-3311.
75. Carroll SF & Collier RJ (1987) Active site of Pseudomonas aeruginosa exotoxin A. Glutamic acid 553 is photolabeled by NAD and shows functional homology with glutamic acid 148 of diphtheria toxin. J Biol Chem 262, 8707-8711.
76. Lobet Y, Cluff CW & Cieplak W Jr (1991) Effect of site-directed mutagenic alterations on ADP-ribosyltransferase activity of the A subunit of Escherichia coli heat-labile enterotoxin. Infect Immun 59, 2870-2879.
77. Cieplak W, Burnette WN, Mar VL, Kaljot KT, Morris CF, Chen KK, Sato H & Keith JM (1988) Identification of a region in the S1 subunit of pertussis toxin that is required for enzymatic activity and that contributes to the formation of a neutralizing antigenic determinant. Proc Natl Acad Sci USA 85, 4667-4671.
78. Burnette WN, Cieplak W, Mar VL, Kaljot KT, Sato H & Keith JM (1988) Pertussis toxin S1 mutant with reduced enzyme activity and a conserved protective epitope. Science 242, 72-74.
79. Burnette WN, Mar VL, Platler BW, Schlotterbeck JD, McGinley MD, Stoney KS, Rohde MF & Kaslow HR (1991) Site-specific mutagenesis of the catalytic subunit of cholera toxin: substituting lysine for arginine 7 causes loss of activity. Infect Immun 59, 4266-4270.
80. O'Neal CJ, Jobling MG, Holmes RK & Hol WG (2005) Structural basis for the activation of cholera toxin by human ARF6-GTP. Science 309, 1093-1096.
81. Lukac M & Collier RJ (1988) Pseudomonas aeruginosa exotoxin A: effects of mutating tyrosine-470 and tyrosine-481 to phenylalanine. Biochemistry 27, 7629-7632.
82. Dolan KM, Lindenmayer G & Olson JC (2000) Functional comparison of the NAD binding cleft of ADP-ribosylating toxins. Biochemistry 39, 8266-8275.
83. Locht C & Antoine R (1995) A proposed mechanism of ADP-ribosylation catalyzed by the pertussis toxin S1 subunit. Biochimie 77, 333-340.
84. Wilson BA, Reich KA, Weinstein BR & Collier RJ (1990) Active-site mutations of diphtheria toxin: effects of replacing glutamic acid-148 with aspartic acid, glutamine, or serine. Biochemistry 29, 8643-8651.
85. Parikh SL & Schramm VL (2004) Transition state structure for ADP-ribosylation of eukaryotic elongation factor 2 catalyzed by diphtheria toxin. Biochemistry 43, 1204-1212.
86. Armstrong S, Yates SP & Merrill AR (2002) Insight into the catalytic mechanism of Pseudomonas aeruginosa exotoxin A. Studies of toxin interaction with eukaryotic elongation factor-2. J Biol Chem 277, 46669-46675.
87. Armstrong S & Merrill AR (2004) Toward the elucidation of the catalytic mechanism of the mono-ADP-ribosyltransferase activity of Pseudomonas aeruginosa exotoxin A. Biochemistry 43, 183-194.
88. Esnouf RM (1997) An extensively modified version of Molscript that includes greatly enhanced coloring capabilities. J Mol Graphics Modelling 15, 132-134.